2026 · 2nd Quarter (Apr 1 - June 30)

NOVOZYMES NORTH AMERICA, INC.

Filed by NOVOZYMES NORTH AMERICA, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 21, 2026
Income: Not reported
Expenses: $140,000.00
Registrant: NOVOZYMES NORTH AMERICA, INC.
Client: NOVOZYMES NORTH AMERICA, INC.
Filing UUID: 2b768f48-1edb-4160-be63-f3247ce7bfea
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

AGR · Agriculture

Issues related to sustainability, animal feed additives, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, biological products in agriculture, biotechnology and biological products, including the National Biotechnology Initiative Act of 2025 (H.R. 2756/S. 1387), and issues related to dietary supplements including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to nutrition, FDA regulation of feed ingredients, and agricultural biotechnology.

Literal federal measure citations: H.R. 2756, S. 1387, H.R. 7366

TRA · Transportation

Issues pertaining to supply chain operations, movement of containers, SHIP IT Act (not yet introduced) related issues, and tariffs.

ENV · Environment/Superfund

Issues related to renewable fuels, E15, and biotechnology policy; no specific legislation.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.